News

As most pharmacists likely know, the Drug Supply Chain Security Act (DSCSA) is a critical piece of legislation designed to ensure that every prescription drug that reaches a patient has been verified as safe, authentic, and uncompromised. The DSCSA is federal law: Non-compliance can lead to severe consequences, including substantial fines, suspension or revocation of licenses, and even criminal charges.

The FDA’s DSCSA enforcement is actively underway, with all trading partners expected to be working towards full electronic traceability. The cost of noncompliance far outweighs the investment in a robust solution, and pharmacies that have not yet begun should immediately prioritize implementing DSCSA solutions to lower their risk of enforcement action and ensure continued access to medications. While the core requirements for package-level tracing became effective in November 2024, the FDA has provided extended compliance deadlines for dispensers who have already initiated their systems and processes.

A Refresher on the Drug Supply Chain Security Act (DSCSA)

At its core, the goal of the DSCSA is for pharmacies to establish an electronic, interoperable system to trace prescription drugs at the package level. The most substantial challenge for pharmacies in achieving full DSCSA compliance revolves around transitioning to accept and securely store transaction information (TI) and transaction statements (TS) in an electronic, interoperable format, predominantly using the GS1 Electronic Product Code Information Services (EPCIS) standard.

The clock has been ticking towards greater DSCSA enforcement. While the US Food and Drug Administration (FDA) established a stabilization period for enhanced drug distribution security requirements that concluded on November 27, 2024, it’s crucial for dispensers to understand the latest guidance. The FDA’s extended compliance deadlines for trading partners, including dispensers, are intended for those who have initiated systems and processes for package-level traceability. Those deadlines are as follows:

• Dispensers with 26 or more full-time employees (licensed pharmacists or qualified pharmacy technicians): May be exempt from certain requirements until November 27, 2025, provided they have initiated their electronic DSCSA data connections and processes.
• Dispensers with 25 or fewer full-time licensed pharmacist/tech employees as of Nov 27, 2024): May be exempt until November 27, 2026, under the same condition of having initiated necessary systems.

Remember, though, that these exemptions are not a pass to delay action. They underscore the FDA’s expectation that all trading partners are actively working towards full, interoperable, electronic tracing. The November 2024 date remains a significant milestone by which systems should have been initiated. If you haven’t gotten started on this initiative yet, you are unfortunately under the eight ball and will need to move quickly to procure a solution and ensure compliance with the DSCSA.

While initially seeming like an added burden, proper DSCSA systems can streamline receiving processes, improve inventory management, and provide clearer audit trails, which is ultimately a good thing in terms of operational efficiency. For dispensers, understanding and implementing DSCSA requirements is a fundamental aspect of patient care and operational integrity—and with key DSCSA compliance deadlines approaching, now is a great time to solidify your compliance strategy.

The Road to Compliance: Understanding Key Requirements for Dispensers

DSCSA compliance is multifaceted, touching nearly every aspect of how pharmacies receive and dispense medications. Its importance cannot be overstated: The core objective of DSCSA is to protect patients from counterfeit, stolen, contaminated, or otherwise harmful drugs. By enabling robust track and trace capabilities, pharmacies play a vital role in preventing these dangerous products from reaching patients while demonstrating a commitment to the highest standards of safety and care—bolstering trust among patients, prescribers, and trading partners.

Dispensers are at the critical final point in the supply chain before medications reach patients. Key responsibilities under DSCSA include:

• Receiving data electronically. This means adopting systems to accept and store transaction information (TI) and transaction statements (TS) in a secure, electronic, and interoperable format, primarily the GS1 Electronic Product Code Information Services (EPCIS) standard.
• Product verification. The systems you implement must be able to verify the product identifier (including the NDC, serial number, lot number, and expiration date) on prescription drug packages.
• Suspect and illegitimate product handling. Your pharmacy will need to implement processes and standard operating procedures to identify, quarantine, investigate, and report suspect or illegitimate products to the FDA and trading partners.
• Record-keeping. You’ll need to maintain DSCSA-required documentation (TI, TS) for at least six years.

DSCSA’s rules are undeniably complicated. Achieving compliance means pharmacies will need to navigate complex technical integrations, significant workflow changes, extensive data management, and careful resource allocation. But it all boils down to this: Fusion360 will do all the work for you.

Fusion360: Your Turnkey Track and Trace DSCSA Solution

Fusion understands the unique pressures faced by pharmacies. Our Fusion360 DSCSA track-and-trace platform is a powerful, turnkey track and trace solution specifically designed to simplify DSCSA compliance for dispensers.

Fusion360 empowers your pharmacy to meet DSCSA mandates with confidence by:

• Streamlining EPCIS data exchange. Receive, process, and manage electronic TI and TS from your suppliers.
• Offering a “turnkey” experience. Fusion360 is designed for ease of use and speedy implementation, minimizing disruption to your existing operations and helping you meet the “initiated systems” requirement for compliance extensions.
• Simplifying product verification. Integrated tools to efficiently verify product identifiers, ensuring the authenticity of medications.
• Automating record-keeping. Securely store all DSCSA-required data for the mandated six-year period, ensuring you are audit-ready.
• Facilitating suspect product management. Robust workflows to help identify, quarantine, investigate, and report potentially suspect or illegitimate products in line with FDA guidance.

Don’t Wait: Secure Fusion360 and Ensure DSCSA Compliance

The DSCSA landscape continues to evolve, but the objective remains clear: a safer, more secure pharmaceutical supply chain. While extensions provide some breathing room for dispensers who are actively implementing solutions, the expectation for proactive compliance is not going anywhere.

Waiting until the last minute to address DSCSA requirements introduces unnecessary risk to your patients and your business. Take control of your DSCSA compliance today with Fusion360.

TAKE ACTION NOW

---